Sign in
BIOT Stock Price, Chart, Stats & News
L&G Pharma Breakthrough UCITS ETF
Save
L&G Pharma Breakthrough UCITS ETF (BIOT) does not currently pay a dividend.
Sector Equity Biotechnology
Category
0.49%
Expense ratio
–
Assets
25.23%
1Y return
BIOT chart
About
The L&G Pharma Breakthrough UCITS ETF is designed to mirror the financial performance generated by the Solactive Pharma Breakthrough Value Index.
Top 10 BIOT holdings
| Holding | Ownership |
|---|---|
Health care 5.52% | |
Health care 5.42% | |
Health care 3.76% | |
Health care 3.38% | |
Health care 3.33% | |
Health care 3.28% | |
Health care 3.25% | |
Health care 3.18% | |
Health care 3.12% | |
Health care 3.10% |
Similar securities
Based on sector and market capitalization
Report issue